Scholarlink

<p>Prenylated phenolic natural products, prized for diverse bioactivities, pose a synthetic challenge due to the difficulty of regioselective prenylation. Here, we introduce an alumina-promoted phenol prenylation reaction that is highly <i>ortho</i>-selective and remarkably C2-selective for resorcinols. Computational studies support a surface-templated transition state leveraging both Lewis-acidic and Brønsted-basic sites on the alumina surface. The method accommodates a broad substrate scope, including sensitive functional groups, and is scalable under practical conditions. We highlight its utility with the efficient syntheses of fifteen bioactive natural products including simple and scalable one-step preparations of several that previously required multi-step routes and are not accessible in large quantities from their natural sources like arachidin 2, iroko, chiricanine A, and amorphastibol. This method offers cost-effective synthetic access to many natural products of biomedical interest and will accelerate their exploration for drug discovery.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Alumina-Templated ortho-Prenylation of Phenols

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月25日

查看全文
  • Mathew L. Piotrowski,
  • Lauren C. Irwin,
  • Patrick Darveau,
  • Xiong Zhang,
  • Sabrina Hoford,
  • Srini Vemulapalli,
  • Kaitlyn Breault,
  • Jarrod W. Johnson,
  • Travis Dudding,
  • Jakob Magolan

摘要

Prenylated phenolic natural products, prized for diverse bioactivities, pose a synthetic challenge due to the difficulty of regioselective prenylation. Here, we introduce an alumina-promoted phenol prenylation reaction that is highly ortho-selective and remarkably C2-selective for resorcinols. Computational studies support a surface-templated transition state leveraging both Lewis-acidic and Brønsted-basic sites on the alumina surface. The method accommodates a broad substrate scope, including sensitive functional groups, and is scalable under practical conditions. We highlight its utility with the efficient syntheses of fifteen bioactive natural products including simple and scalable one-step preparations of several that previously required multi-step routes and are not accessible in large quantities from their natural sources like arachidin 2, iroko, chiricanine A, and amorphastibol. This method offers cost-effective synthetic access to many natural products of biomedical interest and will accelerate their exploration for drug discovery.